Molecular Innovations起源于一家在底特律生物化学实验室,创始人Day偶然发现了从血浆中纯化蛋白质,他决定开始自己的公司和出售他的蛋白,他离开了亨利福特开创了Molecular Innovations公司。Molecular Innovations提供了广泛的产品线从新先进的设施产生了广泛的科技产品,包括检测试剂盒,肾素,肾素原,玻连蛋白,纤维蛋白,纤维连接蛋白,血纤维蛋白溶酶原,血纤维蛋白溶酶,抗凝血酶,ELISA试剂盒等,Molecular Innovations致力成为生物化学领域的*。
2017年部分产品报价如下:
品牌 | 货号 | 品名 | 规格 | 目录价格 |
Molecular Innovations, Inc. | 6XDYE | MantisGreen 6X Loading Dye | 4ml | 950 |
Molecular Innovations, Inc. | BTAQ | TaqCurate Blended High Fidelity DNA Polymerase | 200units | 2090 |
Molecular Innovations, Inc. | CDNA | Reality Reverse Transcriptase cDNA Synthesis Kit | 100rxn | 7980 |
Molecular Innovations, Inc. | DNTP | dNTP Deoxynucleotide Solution Mix | 1ml | 950 |
Molecular Innovations, Inc. | HB101 | Mix and Go Competent Cells Strain HB101 | 1ml | 1805 |
Molecular Innovations, Inc. | HTAQ | TaqTivate Hot Start Taq DNA Polymerase | 500units | 3420 |
Molecular Innovations, Inc. | HTAQGREEN | TaqTivate Hot Start Taq MantisGreen Master Mix | 100rxn | 2090 |
Molecular Innovations, Inc. | HTAQMIX | TaqTivate Hot Start Taq Master Mix | 100rxn | 2090 |
Molecular Innovations, Inc. | LADDER-H | High Range DNA Ladder | 0.5ml | 1805 |
Molecular Innovations, Inc. | LADDER-L | Low Range DNA Ladder | 0.5ml | 1805 |
Molecular Innovations, Inc. | LADDER-M | Mid Range DNA Ladder | 0.5ml | 1805 |
Molecular Innovations, Inc. | MMIX | TicTaqGo Detergent Free Multiplex Master Mix | 100rxn | 4180 |
Molecular Innovations, Inc. | NTAQ | TaqRobat Native Taq DNA Polymerase | 500units | 2090 |
Molecular Innovations, Inc. | NTAQGREEN | TaqRobat Native Taq MantisGreen 2X Master Mix | 500rxn | 3990 |
Molecular Innovations, Inc. | NTAQMIX | TaqRobat Native Taq 2X Master Mix | 500rxn | 3990 |
Molecular Innovations, Inc. | PYFI | PyFi High Fidelity DNA Polymerase | 200units | 2090 |
Molecular Innovations, Inc. | QMIX | TaqCelerate qPCR Master Mix | 100rxn | 2850 |
Molecular Innovations, Inc. | 6XDYE | MantisGreen 6X Loading Dye | 8ml | 1805 |
Molecular Innovations, Inc. | BTAQ | TaqCurate Blended High Fidelity DNA Polymerase | 500units | 4180 |
Molecular Innovations, Inc. | CDNA | Reality Reverse Transcriptase cDNA Synthesis Kit | 200rxn | 15580 |
Molecular Innovations, Inc. | DNTP | dNTP Deoxynucleotide Solution Mix | 2ml | 1805 |
Molecular Innovations, Inc. | HB101 | Mix and Go Competent Cells Strain HB101 | 2ml | 3515 |
Molecular Innovations, Inc. | HTAQ | TaqTivate Hot Start Taq DNA Polymerase | 1000units | 6650 |
Molecular Innovations, Inc. | HTAQGREEN | TaqTivate Hot Start Taq MantisGreen Master Mix | 500rxn | 7505 |
Molecular Innovations, Inc. | HTAQMIX | TaqTivate Hot Start Taq Master Mix | 500rxn | 7505 |
Molecular Innovations, Inc. | LADDER-H | High Range DNA Ladder | 1ml | 3515 |
Molecular Innovations, Inc. | LADDER-L | Low Range DNA Ladder | 1ml | 3515 |
Molecular Innovations, Inc. | LADDER-M | Mid Range DNA Ladder | 1ml | 3515 |
Molecular Innovations, Inc. | MMIX | TicTaqGo Detergent Free Multiplex Master Mix | 500rxn | 18905 |
Molecular Innovations, Inc. | NTAQ | TaqRobat Native Taq DNA Polymerase | 1000units | 3705 |
Molecular Innovations, Inc. | NTAQGREEN | TaqRobat Native Taq MantisGreen 2X Master Mix | 1000rxn | 7790 |
Molecular Innovations, Inc. | NTAQMIX | TaqRobat Native Taq 2X Master Mix | 1000rxn | 7790 |
Molecular Innovations, Inc. | PYFI | PyFi High Fidelity DNA Polymerase | 500units | 4180 |
Molecular Innovations, Inc. | QMIX | TaqCelerate qPCR Master Mix | 500rxn | 9405 |
Molecular Innovations, Inc. | 6X-HISCPAI | Human PAI-1 (stable mutant – N-terminal poly-histidine tag) | 0.5mg | 9730 |
Molecular Innovations, Inc. | 6X-HISHPAI-A | Human PAI-1 (wild type active fraction – N-terminal poly-histidine tag) | 0.5mg | 9730 |
Molecular Innovations, Inc. | 6X-HISRPAI-A | Rat PAI-1 (wild type active fraction – N-terminal poly-histidine tag) | 0.5mg | 12530 |
Molecular Innovations, Inc. | CPAI | Human PAI-1 (stable mutant form) | 0.5mg | 9730 |
Molecular Innovations, Inc. | CPAI-P1NBD | Human PAI-1 stable mutant NBD labeled at the scissile bond of the reactive loop | 0.5mg | 9730 |
Molecular Innovations, Inc. | CPAI-P9NBD | Human PAI-1 stable mutant NBD labeled at the reactive center loop | 0.5mg | 9730 |
Molecular Innovations, Inc. | CPAI-Q123K | Human PAI-1 (stable vitronectin reduced binding mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | CPAI-TPA | Human PAI-1 tPA complex | 0.1mg | 4760 |
Molecular Innovations, Inc. | CPAI-UPA | Human PAI-1 uPA complex | 0.1mg | 4760 |
Molecular Innovations, Inc. | CYPAI | Cyno Monkey PAI-1 (wild type active fraction) | 0.5mg | 12530 |
Molecular Innovations, Inc. | CYPAI-C | Cyno Monkey PAI-1 (elastase cleaved wild type) | 0.5mg | 12530 |
Molecular Innovations, Inc. | CYPAI-L | Cyno Monkey PAI-1 (wild type latent fraction) | 0.5mg | 12530 |
Molecular Innovations, Inc. | GLYCPAI | Human PAI-1 (Glycosylated – stable mutant) | 0.5mg | 13300 |
Molecular Innovations, Inc. | GLYDPAI-I91L | Glycosylated Canine (Dog) PAI-1 Stable Mutant | 0.5mg | 13300 |
Molecular Innovations, Inc. | GLYDPAI-L | Glycosylated Canine (Dog) PAI-1 Wild Type Latent Fraction | 0.5mg | 13300 |
Molecular Innovations, Inc. | GLYHPAI-A | Glycosylated Human PAI-1 (active form) | 0.5mg | 13300 |
Molecular Innovations, Inc. | GLYHPAI-A-AF488 | Glycosylated Human PAI-1 (Alexa Fluor 488 labeled active form) | 0.5mg | 13300 |
Molecular Innovations, Inc. | GLYHPAI-L | Glycosylated Human PAI-1 (latent form) | 0.5mg | 13300 |
Molecular Innovations, Inc. | GLYMPAI-I91L | Glycosylated Mouse PAI-1 (stable mutant) | 0.5mg | 13300 |
Molecular Innovations, Inc. | GLYRPAI-I91L | Glycosylated Rat PAI-1 (stable mutant) | 0.5mg | 13300 |
Molecular Innovations, Inc. | HPAI-A335E | Human PAI-1 substrate form P12 glutamate mutant | 0.5mg | 9730 |
Molecular Innovations, Inc. | HPAI-I91L | Human PAI-1 (point mutation stable form) | 0.5mg | 9730 |
Molecular Innovations, Inc. | HPAI-P1NBD | Human PAI-1 NBD labeled at the scissile bond of the reactive loop | 0.5mg | 9730 |
Molecular Innovations, Inc. | HPAI-P9NBD | Human PAI-1 NBD labeled at the reactive center loop | 0.5mg | 9730 |
Molecular Innovations, Inc. | HPAI-Q123K | Human PAI-1 (vitronectin reduced binding mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | HPAI-QR | Human PAI-1 (Vitronectin binding negative mutant, wild type active fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | HPAI-R76E-I91L | PAI-1 mutant – stable, no LRP binding | 0.5mg | 9730 |
Molecular Innovations, Inc. | HPAI-RR | Human PAI-1 (substrate form – P12 Arginine P14 Arginine double mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | HPAI-T333R | Human PAI-1 substrate form P14 arginine mutant | 0.5mg | 9730 |
Molecular Innovations, Inc. | HPAI-YSY | tPA Specific Human PAI-1 | 0.5mg | 9730 |
Molecular Innovations, Inc. | MPAI | Mouse PAI-1 (wild type active fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | MPAI-BIO | Mouse PAI-1 (Biotin labeled active fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | MPAI-I91L | Mouse PAI-1 (stable mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | MPAI-L | Mouse PAI-1 (wild type latent form) | 0.5mg | 9730 |
Molecular Innovations, Inc. | MPAI-L-BIO | Mouse PAI-1 (Biotin labeled latent fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | MPAI-TPA | Mouse PAI-1 tPA complex | 0.1mg | 5530 |
Molecular Innovations, Inc. | NTAF488CPAI | Human PAI-1 (N-terminal Alexa Fluor 488 labeled stable mutant) | 0.5mg | 13300 |
Molecular Innovations, Inc. | NTAF488PAI-A | Human PAI-1 (N-terminal Alexa Fluor 488 labeled, active fraction) | 0.5mg | 13300 |
Molecular Innovations, Inc. | NTAF488PAI-L | Human PAI-1 (N-terminal Alexa Fluor 488 labeled, latent fraction) | 0.5mg | 13300 |
Molecular Innovations, Inc. | NTAF594CPAI | Human PAI-1 (N-terminal Alexa Fluor 594 labeled stable mutant) | 0.5mg | 13300 |
Molecular Innovations, Inc. | NTAF594PAI-A | Human PAI-1 (N-terminal Alexa Fluor 594 labeled, active fraction) | 0.5mg | 13300 |
Molecular Innovations, Inc. | NTAF594PAI-L | Human PAI-1 (N-terminal Alexa Fluor 594 labeled, latent fraction) | 0.5mg | 13300 |
Molecular Innovations, Inc. | NTBIOCPAI | Human PAI-1 (N-terminal biotin labeled stable mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | NTBIOMPAI-I91L | Mouse PAI-1 (N-terminal biotin labeled stable mutant) | 0.5mg | 12530 |
Molecular Innovations, Inc. | NTBIOPAI-A | Human PAI-1 (N-terminal biotin labeled, active fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | NTBIOPAI-L | Human PAI-1 (N-terminal biotin labeled, latent fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | NTCYSCPAI | Human PAI-1 (N-terminal cysteine stable mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | NTCYSCPAI-R76E | Human PAI-1 (N-terminal cysteine LRP non-binding stable mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | NTCYSCPAI-T333R | Human PAI-1 (N-terminal cysteine substrate form stable mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | NTCYSPAI-A | Human PAI-1 (N-terminal cysteine, active fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | NTCYSPAI-L | Human PAI-1 (N-terminal cysteine mutant, latent fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | NTFLCPAI | Human PAI-1 (N-terminal fluorescein labeled stable mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | NTFLPAI-A | Human PAI-1 (N-terminal fluorescein labeled, active fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | NTFLPAI-L | Human PAI-1 (N-terminal fluorescein labeled, latent fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | PAI-A | Human PAI-1 (wild type active fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | PAI-A-AN | Peptide annealed human PAI-1 | 0.5mg | 9730 |
Molecular Innovations, Inc. | PAI-C | Human PAI-1 (wild type – elastase cleaved) | 0.5mg | 9730 |
Molecular Innovations, Inc. | PAI-L | Human PAI-1 (wild type latent fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | PEP-1 | Ac-TVASSSTA Octapeptide | 5mg | 6790 |
Molecular Innovations, Inc. | POPAI | Porcine PAI-1 (wild type active form) | 0.5mg | 9730 |
Molecular Innovations, Inc. | POPAI-TPA | Porcine PAI-1 tPA complex | 05mg | 5530 |
Molecular Innovations, Inc. | RbPAI | Rabbit PAI-1 (wild type active) | 0.5mg | 9730 |
Molecular Innovations, Inc. | RbPAI-I91L | Rabbit PAI-1 (stable mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | RbPAI-L | Rabbit PAI-1 (wild type latent) | 0.5mg | 9730 |
Molecular Innovations, Inc. | RbPAI-L-BIO | Rabbit PAI-1 (Biotin labeled latent fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | RPAI | Rat PAI-1 (wild type active form) | 0.5mg | 9730 |
Molecular Innovations, Inc. | RPAI-AF488 | Rat PAI-1 (Alexa Fluor 488 labeled wild type active form) | 0.5mg | 11132 |
Molecular Innovations, Inc. | RPAI-BIO | Rat PAI-1 (Biotin labeled active fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | RPAI-I91L | Rat PAI-1 (stable mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | RPAI-I91L-BIO | Rat PAI-1 (Biotin labeled stable mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | RPAI-L | Rat PAI-1 (wild type latent form) | 0.5mg | 9730 |
Molecular Innovations, Inc. | RPAI-L-AF488 | Rat PAI-1 (Alexa Fluor 488 labeled wild type latent form) | 0.5mg | 11130 |
Molecular Innovations, Inc. | RPAI-L-BIO | Rat PAI-1 (Biotin labeled latent fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | RPAI-P1NBD | Rat PAI-1 (NBD labeled at the scissile bond of the reactive center loop) | 0.5mg | 12530 |
Molecular Innovations, Inc. | RPAI-P9NBD | Rat PAI-1 NBD labeled at the reactive center loop | 0.5mg | 12530 |
Molecular Innovations, Inc. | S119C-L-NBD | Human PAI-1 (NBD labeled vitronectin reporter mutant latent fraction) | 0.5mg | 9730 |
Molecular Innovations, Inc. | S119C-NBD | Human PAI-1 (NBD labeled vitronectin reporter mutant) | 0.5mg | 9730 |
Molecular Innovations, Inc. | 6X-HISCPAI | Human PAI-1 (stable mutant – N-terminal poly-histidine tag) | 1mg | 15960 |
Molecular Innovations, Inc. | 6X-HISHPAI-A | Human PAI-1 (wild type active fraction – N-terminal poly-histidine tag) | 1mg | 15960 |
Molecular Innovations, Inc. | 6X-HISRPAI-A | Rat PAI-1 (wild type active fraction – N-terminal poly-histidine tag) | 1mg | 20160 |
Molecular Innovations, Inc. | CPAI | Human PAI-1 (stable mutant form) | 1mg | 15960 |
Molecular Innovations, Inc. | CPAI-P1NBD | Human PAI-1 stable mutant NBD labeled at the scissile bond of the reactive loop | 1mg | 18200 |
Molecular Innovations, Inc. | CPAI-P9NBD | Human PAI-1 stable mutant NBD labeled at the reactive center loop | 1mg | 18200 |
Molecular Innovations, Inc. | CPAI-Q123K | Human PAI-1 (stable vitronectin reduced binding mutant) | 1mg | 15960 |
Molecular Innovations, Inc. | CPAI-TPA | Human PAI-1 tPA complex | 1mg | 40040 |
Molecular Innovations, Inc. | CPAI-UPA | Human PAI-1 uPA complex | 1mg | 40040 |
Molecular Innovations, Inc. | CYPAI | Cyno Monkey PAI-1 (wild type active fraction) | 1mg | 20160 |
Molecular Innovations, Inc. | CYPAI-C | Cyno Monkey PAI-1 (elastase cleaved wild type) | 1mg | 23730 |
Molecular Innovations, Inc. | CYPAI-L | Cyno Monkey PAI-1 (wild type latent fraction) | 1mg | 20160 |
Molecular Innovations, Inc. | GLYCPAI | Human PAI-1 (Glycosylated – stable mutant) | 1mg | 21280 |
Molecular Innovations, Inc. | GLYDPAI-I91L | Glycosylated Canine (Dog) PAI-1 Stable Mutant | 1mg | 21280 |
Molecular Innovations, Inc. | GLYDPAI-L | Glycosylated Canine (Dog) PAI-1 Wild Type Latent Fraction | 1mg | 21280 |
Molecular Innovations, Inc. | GLYHPAI-A | Glycosylated Human PAI-1 (active form) | 1mg | 21280 |
Molecular Innovations, Inc. | GLYHPAI-A-AF488 | Glycosylated Human PAI-1 (Alexa Fluor 488 labeled active form) | 1mg | 21280 |
Molecular Innovations, Inc. | GLYHPAI-L | Glycosylated Human PAI-1 (latent form) | 1mg | 21280 |
Molecular Innovations, Inc. | GLYMPAI-I91L | Glycosylated Mouse PAI-1 (stable mutant) | 1mg | 21280 |
Molecular Innovations, Inc. | GLYRPAI-I91L | Glycosylated Rat PAI-1 (stable mutant) | 1mg | 21280 |
Molecular Innovations, Inc. | HPAI-A335E | Human PAI-1 substrate form P12 glutamate mutant | 1mg | 15960 |
Molecular Innovations, Inc. | HPAI-I91L | Human PAI-1 (point mutation stable form) | 1mg | 15960 |
Molecular Innovations, Inc. | HPAI-P1NBD | Human PAI-1 NBD labeled at the scissile bond of the reactive loop | 1mg | 18200 |
Molecular Innovations, Inc. | HPAI-P9NBD | Human PAI-1 NBD labeled at the reactive center loop | 1mg | 18200 |
Molecular Innovations, Inc. | HPAI-Q123K | Human PAI-1 (vitronectin reduced binding mutant) | 1mg | 15960 |
Molecular Innovations, Inc. | HPAI-QR | Human PAI-1 (Vitronectin binding negative mutant, wild type active fraction) | 1mg | 15960 |
Molecular Innovations, Inc. | HPAI-R76E-I91L | PAI-1 mutant – stable, no LRP binding | 1mg | 15960 |
Molecular Innovations, Inc. | HPAI-RR | Human PAI-1 (substrate form – P12 Arginine P14 Arginine double mutant) | 1mg | 15960 |
Molecular Innovations, Inc. | HPAI-T333R | Human PAI-1 substrate form P14 arginine mutant | 1mg | 15960 |
Molecular Innovations, Inc. | HPAI-YSY | tPA Specific Human PAI-1 | 1mg | 15960 |
Molecular Innovations, Inc. | MPAI | Mouse PAI-1 (wild type active fraction) | 1mg | 18200 |
Molecular Innovations, Inc. | MPAI-BIO | Mouse PAI-1 (Biotin labeled active fraction) | 1mg | 18200 |
Molecular Innovations, Inc. | MPAI-I91L | Mouse PAI-1 (stable mutant) | 1mg | 18200 |
Molecular Innovations, Inc. | MPAI-L | Mouse PAI-1 (wild type latent form) | 1mg | 18200 |
Molecular Innovations, Inc. | MPAI-L-BIO | Mouse PAI-1 (Biotin labeled latent fraction) | 1mg | 18200 |
Molecular Innovations, Inc. | MPAI-TPA | Mouse PAI-1 tPA complex | 1mg | 44240 |
Molecular Innovations, Inc. | NTAF488CPAI | Human PAI-1 (N-terminal Alexa Fluor 488 labeled stable mutant) | 1mg | 21280 |
Molecular Innovations, Inc. | NTAF488PAI-A | Human PAI-1 (N-terminal Alexa Fluor 488 labeled, active fraction) | 1mg | 21280 |
Molecular Innovations, Inc. | NTAF488PAI-L | Human PAI-1 (N-terminal Alexa Fluor 488 labeled, latent fraction) | 1mg | 21280 |
Molecular Innovations, Inc. | NTAF594CPAI | Human PAI-1 (N-terminal Alexa Fluor 594 labeled stable mutant) | 1mg | 21280 |
Molecular Innovations, Inc. | NTAF594PAI-A | Human PAI-1 (N-terminal Alexa Fluor 594 labeled, active fraction) | 1mg | 21280 |
Molecular Innovations, Inc. | NTAF594PAI-L | Human PAI-1 (N-terminal Alexa Fluor 594 labeled, latent fraction) | 1mg | 21280 |
Molecular Innovations, Inc. | NTBIOCPAI | Human PAI-1 (N-terminal biotin labeled stable mutant) | 1mg | 18200 |
Molecular Innovations, Inc. | NTBIOMPAI-I91L | Mouse PAI-1 (N-terminal biotin labeled stable mutant) | 1mg | 23730 |
Molecular Innovations, Inc. | NTBIOPAI-A | Human PAI-1 (N-terminal biotin labeled, active fraction) | 1mg | 18200 |
Molecular Innovations, Inc. | NTBIOPAI-L | Human PAI-1 (N-terminal biotin labeled, latent fraction) | 1mg | 18200 |
Molecular Innovations, Inc. | NTCYSCPAI | Human PAI-1 (N-terminal cysteine stable mutant) | 1mg | 15960 |
Molecular Innovations, Inc. | NTCYSCPAI-R76E | Human PAI-1 (N-terminal cysteine LRP non-binding stable mutant) | 1mg | 15960 |
Molecular Innovations, Inc. | NTCYSCPAI-T333R | Human PAI-1 (N-terminal cysteine substrate form stable mutant) | 1mg | 15960 |
Molecular Innovations, Inc. | NTCYSPAI-A | Human PAI-1 (N-terminal cysteine, active fraction) | 1mg | 15960 |
Molecular Innovations, Inc. | NTCYSPAI-L | Human PAI-1 (N-terminal cysteine mutant, latent fraction) | 1mg | 15960 |
Molecular Innovations, Inc. | NTFLCPAI | Human PAI-1 (N-terminal fluorescein labeled stable mutant) | 1mg | 18200 |
Molecular Innovations, Inc. | NTFLPAI-A | Human PAI-1 (N-terminal fluorescein labeled, active fraction) | 1mg | 18200 |
Molecular Innovations, Inc. | NTFLPAI-L | Human PAI-1 (N-terminal fluorescein labeled, latent fraction) | 1mg | 18200 |